Medtronic constant blood monitoring devices approved for youths

03/13/2007 | Pioneer Press (St. Paul, Minn.) · Bloomberg Businessweek

Medtronic received FDA approval for its Guardian Real-Time System glucose monitor and its Paradigm Real-Time System insulin pump that incorporate blood sugar monitoring technology for use in those aged 7 to 17. The devices work by placing sensors under the skin to constantly monitor blood sugar levels.

View Full Article in:

Pioneer Press (St. Paul, Minn.) · Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC